93 related articles for article (PubMed ID: 20379198)
1. The cleavage of HuR interferes with its transportin-2-mediated nuclear import and promotes muscle fiber formation.
Beauchamp P; Nassif C; Hillock S; van der Giessen K; von Roretz C; Jasmin BJ; Gallouzi IE
Cell Death Differ; 2010 Oct; 17(10):1588-99. PubMed ID: 20379198
[TBL] [Abstract][Full Text] [Related]
2. Involvement of transportin 2-mediated HuR import in muscle cell differentiation.
van der Giessen K; Gallouzi IE
Mol Biol Cell; 2007 Jul; 18(7):2619-29. PubMed ID: 17475777
[TBL] [Abstract][Full Text] [Related]
3. HuR and myogenesis: being in the right place at the right time.
von Roretz C; Beauchamp P; Di Marco S; Gallouzi IE
Biochim Biophys Acta; 2011 Sep; 1813(9):1663-7. PubMed ID: 21315776
[TBL] [Abstract][Full Text] [Related]
4. Transportin 2 regulates apoptosis through the RNA-binding protein HuR.
von Roretz C; Macri AM; Gallouzi IE
J Biol Chem; 2011 Jul; 286(29):25983-91. PubMed ID: 21646354
[TBL] [Abstract][Full Text] [Related]
5. Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR.
Rebane A; Aab A; Steitz JA
RNA; 2004 Apr; 10(4):590-9. PubMed ID: 15037768
[TBL] [Abstract][Full Text] [Related]
6. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation.
Lin FY; Chen YH; Lin YW; Tsai JS; Chen JW; Wang HJ; Chen YL; Li CY; Lin SJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2622-9. PubMed ID: 16990552
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.
Mrena J; Wiksten JP; Thiel A; Kokkola A; Pohjola L; Lundin J; Nordling S; Ristimäki A; Haglund C
Clin Cancer Res; 2005 Oct; 11(20):7362-8. PubMed ID: 16243808
[TBL] [Abstract][Full Text] [Related]
8. Transportin2 functions as importin and mediates nuclear import of HuR.
Güttinger S; Mühlhäusser P; Koller-Eichhorn R; Brennecke J; Kutay U
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2918-23. PubMed ID: 14981248
[TBL] [Abstract][Full Text] [Related]
9. Stau1 negatively regulates myogenic differentiation in C2C12 cells.
Yamaguchi Y; Oohinata R; Naiki T; Irie K
Genes Cells; 2008 Jun; 13(6):583-92. PubMed ID: 18422603
[TBL] [Abstract][Full Text] [Related]
10. Functional antagonism between RNA binding proteins HuR and CUGBP2 determines the fate of COX-2 mRNA translation.
Sureban SM; Murmu N; Rodriguez P; May R; Maheshwari R; Dieckgraefe BK; Houchen CW; Anant S
Gastroenterology; 2007 Mar; 132(3):1055-65. PubMed ID: 17383427
[TBL] [Abstract][Full Text] [Related]
11. The regulation of glucose transporter (GLUT1) expression by the RNA binding protein HuR.
Gantt KR; Cherry J; Richardson M; Karschner V; Atasoy U; Pekala PH
J Cell Biochem; 2006 Oct; 99(2):565-74. PubMed ID: 16639702
[TBL] [Abstract][Full Text] [Related]
12. Role of the RNA-binding protein HuR in human renal cell carcinoma.
Danilin S; Sourbier C; Thomas L; Lindner V; Rothhut S; Dormoy V; Helwig JJ; Jacqmin D; Lang H; Massfelder T
Carcinogenesis; 2010 Jun; 31(6):1018-26. PubMed ID: 20219773
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells.
Ishimaru D; Ramalingam S; Sengupta TK; Bandyopadhyay S; Dellis S; Tholanikunnel BG; Fernandes DJ; Spicer EK
Mol Cancer Res; 2009 Aug; 7(8):1354-66. PubMed ID: 19671677
[TBL] [Abstract][Full Text] [Related]
15. Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis.
Mazroui R; Di Marco S; Clair E; von Roretz C; Tenenbaum SA; Keene JD; Saleh M; Gallouzi IE
J Cell Biol; 2008 Jan; 180(1):113-27. PubMed ID: 18180367
[TBL] [Abstract][Full Text] [Related]
16. HuR knockdown changes the oncogenic potential of oral cancer cells.
Kakuguchi W; Kitamura T; Kuroshima T; Ishikawa M; Kitagawa Y; Totsuka Y; Shindoh M; Higashino F
Mol Cancer Res; 2010 Apr; 8(4):520-8. PubMed ID: 20332213
[TBL] [Abstract][Full Text] [Related]
17. Msi2-mediated MiR7a-1 processing repression promotes myogenesis.
Yang W; Yang L; Wang J; Zhang Y; Li S; Yin Q; Suo J; Ma R; Ye Y; Cheng H; Li J; Hui J; Hu P
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):728-742. PubMed ID: 34877814
[TBL] [Abstract][Full Text] [Related]
18. HuR as a negative posttranscriptional modulator in inflammation.
Katsanou V; Papadaki O; Milatos S; Blackshear PJ; Anderson P; Kollias G; Kontoyiannis DL
Mol Cell; 2005 Sep; 19(6):777-89. PubMed ID: 16168373
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase RNA/FADD/caspase-8 pathway mediates the proapoptotic activity of the RNA-binding protein human antigen R (HuR).
von Roretz C; Gallouzi IE
J Biol Chem; 2010 May; 285(22):16806-13. PubMed ID: 20353946
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas.
Cho NP; Han HS; Soh Y; Lee KY; Son HJ
Pathology; 2007 Dec; 39(6):545-50. PubMed ID: 18027256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
